Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


COHERENT INC   FYE=9 (September)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date9/30/20219/30/20209/30/20199/30/20189/30/20179/30/20169/30/20159/30/20149/30/20139/30/2012
Sales1,487.471,229.001,430.641,902.571,723.31857.39802.46794.64810.13769.09
Total Revenues1,487.471,229.001,430.641,902.571,723.31857.39802.46794.64810.13769.09
Cost of sales918.63818.13944.181,071.88973.04475.99467.06481.25487.86453.10
Gross Profit568.84410.87486.47830.69750.27381.39335.40313.39322.27315.99
Impairment of goodwill--------------------
Amortization of intangible assets2.883.9913.7610.6916.022.842.673.425.0710.38
Research and development124.27115.58117.35132.59119.1781.8081.4679.0782.7978.26
In-process research and development--------------------
Selling, general and administrative303.86270.46272.26293.63292.08169.14149.83154.03149.51138.52
Acquisition-related expenses--------------------
Merger and acquisition costs236.05------------------
Restructuring, impairment and other charges (recoveries)--------------------
Impairment of investment------------(2.02)------
Gain from business combination--------5.42--1.32------
Other impairment charges (recoveries)--(451.03)--(0.77)(2.92)----------
Total Operating Expenses667.05841.05403.37437.67424.77253.78234.65236.52237.37227.16
Operating Income (loss)(98.21)(430.18)83.10393.02325.50127.61100.7576.8784.9088.83
Interest expense18.0617.0419.1225.8534.361.350.050.070.160.09
Write-down of Lumenis investment--------------------
Interest and dividend income0.461.051.121.571.091.140.600.400.230.31
Foreign exchange gain (loss)--------------------
Other-net0.283.44(5.04)(7.19)9.83(4.52)(1.73)2.03(1.47)1.57
Gain on issuance of stock by subsidiary--------------------
Total other income (expense), net(17.33)(12.54)(23.05)(31.46)(23.44)(4.72)(1.18)2.35(1.40)1.79
Income (loss) from continuing operations before income taxes and minority interest(115.54)(442.72)60.05361.56302.06122.9099.5779.2283.5090.62
Current- Foreign----------------27.1538.26
Current: Federal----------------(1.80)(7.86)
Current: State----------------(0.14)(0.10)
Provision for income taxes(8.79)(28.58)6.22114.2093.4135.3923.1620.1117.1427.66
Deferred: Federal----------------(4.02)3.76
Deferred: State----------------(0.02)0.29
Deferred: Foreign----------------(4.04)(6.69)
Minority interest in subsidiaries--------------------
Income (loss) from Continuing Operations------247.36208.6487.5076.41------
Discontinued operations: Gain on disposal of Medical segment--------------------
Discontinued operations: Income (Loss) from Discontinued Medical Segment------0.00(1.52)----------
Income before accounting change--------------------
Cumulative effect of accounting change--------------------
Net income (loss) available to common shareholders(106.75)(414.14)53.83247.36207.1287.5076.4159.1166.3662.96
EPS (BASIC): Income from continuing operations------10.078.523.623.09------
EPS (BASIC): Income from discontinued operations, net of income taxes--------(0.06)----------
EPS (BASIC): Cumulative effect of accounting change--------------------
Basic net income per share(4.38)(17.18)2.2310.078.463.623.092.392.752.67
EPS (DILUTED): Income from continuing operations------9.958.423.583.06------
EPS (DILUTED): Income from discontinued operations, net of income taxes--------(0.06)----------
EPS (DILUTED): Cumulative effect of accounting change--------------------
Diluted net income per share(4.38)(17.18)2.229.958.363.583.062.362.702.62
Basic shares used in computation24.3924.1124.1224.5724.4924.1424.7524.7624.1423.56
Diluted shares used in computation24.3924.1124.2824.8524.7824.4224.9925.0824.5624.03